Table 1.
Association between BCAR4 expression and the clinicopathological parameters of breast cancer patients (all female)
| BCAR4 expression | |||
|---|---|---|---|
| Clinical parameters | Low (n = 40) | High (n = 40) | P value |
| Age | |||
| ≤ 50 | 14 | 17 | 0.491 |
| >50 | 26 | 23 | |
| Tumor size | |||
| ≤ 3 cm | 29 | 19 | 0.041 |
| >3 cm | 11 | 21 | |
| TNM stage | |||
| I–II | 28 | 2 | 0.000 |
| III–IV | 12 | 38 | |
| LN metastasis | |||
| Yes | 15 | 28 | 0.004 |
| No | 25 | 12 | |
| ER status | |||
| Positive | 16 | 18 | 0.651 |
| Negative | 24 | 22 | |
| PR status | |||
| Positive | 18 | 25 | 0.116 |
| Negative | 22 | 15 | |
| HER2 status | |||
| Positive | 20 | 22 | 0.654 |
| Negative | 20 | 18 | |
| Molecular subtype | |||
| Luminal A | 16 | 12 | 0.446 |
| Luminal B | 9 | 10 | |
| HER2 + | 13 | 12 | |
| Basal-like | 2 | 6 | |